Santé Active Edition – Synergy Pharm: Medical Writing Solutions
We have been serving the pharmaceutical industry, and more generally the scientific research community, for more than 30 years.
Every member of our team is an experienced medical writer with a PhD, and all are native English or French speakers with bilingual proficiency in French and English. We design and write medical marketing documents intended for the scientific community, healthcare professionals or the general public, as well as all the regulatory and clinical documentation required at the various stages of drug development, regardless of the therapeutic area. We also provide an editorial assistance service to support you in the publication of your research: from the correction of your article to its submission, and the drafting of responses to reviewers.
We work accurately and efficiently to meet your deadlines, while our compliance with international standards (CONSORT, ICH, etc.), systematic proofreading between medical writers, and attention to detail guarantee that your documents will be of the highest quality. Our adaptability and responsiveness lead us to develop privileged and ongoing relationships with our clients.
Each project is unique, and our team at Santé Active Edition-Synergy Pharm are on hand to adapt and respond to your requirements. Do not hesitate to contact us to discuss your needs, we are looking forward to assisting you with your projects!
Beware of predatory journals!
Predatory journals bias science through the publication of low-quality, non-peer-reviewed articles.
The scale of this problem has recently been highlighted in the latest news round-up from Nature: a recent analysis found that 164,000 articles published by potentially predatory journals from 2015 to 2017 were indexed in the Scopus database, accounting for almost 3% of the articles indexed during this period.
A previous analysis found that some predatory journals were also indexed in PubMed.
These criteria and tools can help you recognize predatory journals.
International Day of Women and Girls in Science
On the International Day of Women and Girls in Science, we wish to recognise the contribution of our team of female medical and scientific writers. Each member of our medical writing team has a PhD in science and has post-doctoral research experience. For several years they have been helping our clients to showcase their results: writing, editing, and rewriting publications for peer-reviewed journals, conference summaries, posters and slideshow presentations; drafting regulatory and clinical documents (IMPDs, IBs, CSPs, CSRs, CTDs, PIPs, CERs, etc.); producing lay texts containing key medical information for patients (website content, brochures, sketchnotes, etc.); and translating scientific documents.
Fight against sleeping sickness
Sanofi renews partnership with the World Health Organization (WHO) for 5 extra years, thereby consolidating a 20-year collaboration to fight Neglected Tropical Diseases (NTDs) and eliminate sleeping sickness before 2030! https://www.sanofi.com/en/media-room/press-releases/2020/2020-12-15-07-00-00
Among its recent activities, Synergy Pharm is proud of its participation in the project for the first all-oral treatment for sleeping sickness — a disease caused by the Trypanosoma brucei gambiense parasite and transmitted to humans by the tsetse fly. Fexinidazole is the result of a fruitful collaboration between the Drugs for Neglected Diseases initiative (DNDi) — an international, non-profit, independent research organization — and Sanofi. A short film by the DNDi tells the story of doctors in the Democratic Republic of Congo and their role in developing this revolutionary treatment: https://www.youtube.com/watch?v=Tk31iucWYdE. This short film has won the “Grand Prix” at the first-ever WHO “Health For All Film Festival”.
January 30, 2021 is World Neglected Tropical Diseases Day: Our congratulations to Sanofi for the inclusion of Fexinidazole Winthrop° (fexinidazole) in the “Honours List” of the 2020 Prescrire Awards!